BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17763403)

  • 1. How, why, and when does primary biliary cirrhosis recur after liver transplantation?
    Williams R; Gershwin ME
    Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 3. The timing of liver transplantation in primary biliary cirrhosis.
    Angulo P; Dickson ER
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 8. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 9. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Talwalkar JA; Gossard AA
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
    Mayo MJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary biliary cirrhosis: therapeutic advances.
    Czul F; Peyton A; Levy C
    Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 14. Ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B
    Semin Liver Dis; 1997 May; 17(2):125-8. PubMed ID: 9170199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
    Poupon R; Chrétien Y; Chazouillères O; Poupon RE
    J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
    [No Abstract]   [Full Text] [Related]  

  • 16. Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom.
    Corpechot C; Poupon R
    Hepatology; 2007 Oct; 46(4):963-5. PubMed ID: 17894325
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
    Corpechot C; Chazouilleres O
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate for treatment of primary biliary cirrhosis.
    Bonis PA; Kaplan M
    Hepatology; 2006 Mar; 43(3):632; author reply 632-3. PubMed ID: 16496314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.